Analytical Data
-
Gene name
STC1
- Application
-
Alternative Names
STC1;STC;Stanniocalcin-1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P52823
-
Expression Region
1-247aa
-
AA Sequence
MLQNSAVLLV LVISASATHE AEQNDSVSPR KSRVAAQNSA EVVRCLNSAL QVGCGAFACL ENSTCDTDGM YDICKSFLYS AAKFDTQGKA FVKESLKCIA NGVTSKVFLA IRRCSTFQRM IAEVQEECYS KLNVCSIAKR NPEAITEVVQ LPNHFSNRYY NRLVRSLLEC DEDTVSTIRD SLMEKIGPNM ASLFHILQTD HCAQTHPRAD FNRRRTNEPQ KLKVLLRNLR GEEDSPSHIK RTSHESA
-
Molecular Weight
27 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
STC1 (Stanniocalcin 1) is a glycoprotein originally identified for its role in calcium and phosphate homeostasis in fish, acting as a hormone secreted by the corpuscles of Stannius. Recent studies have revealed its broader biological significance, including involvement in various cellular processes such as apoptosis, inflammation, and cancer progression. Dysregulation of STC1 expression has been linked to several pathological conditions, including tumors and cardiovascular diseases, making it a focus of interest for therapeutic research. The recombinant production of STC1 has become essential for further understanding its functional properties and mechanisms. Utilizing techniques such as recombinant DNA technology, researchers can produceSTC1 in various expression systems, facilitating studies on its structure-function relationships and potential applications in biomedical research. The insights gained from these studies could pave the way for new diagnostic and therapeutic strategies targeting STC1-related pathways, thereby enhancing our understanding of its role in health and disease. As research continues to evolve, STC1’s multifaceted role in human physiology and pathology remains a vibrant field of investigation.











